You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

MAXIDEX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Maxidex, and when can generic versions of Maxidex launch?

Maxidex is a drug marketed by Alcon and Novartis and is included in two NDAs.

The generic ingredient in MAXIDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.

US ANDA Litigation and Generic Entry Outlook for Maxidex

A generic version of MAXIDEX was approved as dexamethasone by XSPIRE PHARMA on April 28th, 1983.

  Start Trial

Drug patent expirations by year for MAXIDEX
Drug Prices for MAXIDEX

See drug prices for MAXIDEX

Recent Clinical Trials for MAXIDEX

Identify potential brand extensions & 505(b)(2) entrants

Emory UniversityPhase 2
Janssen, LPPhase 2
TakedaPhase 2

See all MAXIDEX clinical trials

Pharmacology for MAXIDEX

US Patents and Regulatory Information for MAXIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon MAXIDEX dexamethasone sodium phosphate OINTMENT;OPHTHALMIC 083342-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis MAXIDEX dexamethasone SUSPENSION/DROPS;OPHTHALMIC 013422-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.